Innoviva

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Innoviva and other ETFs, options, and stocks.

About INVA

Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI.

CEO

Pavel Raifeld

CEOPavel Raifeld

Employees

127

Employees127

Headquarters

Burlingame, California

HeadquartersBurlingame, California

Founded

1996

Founded1996

Employees

127

Employees127

INVA Key Statistics

Market cap

1.35B

Market cap1.35B

Price-Earnings ratio

-21.67

Price-Earnings ratio-21.67

Dividend yield

—

Dividend yield—

Average volume

1.04M

Average volume1.04M

High today

$21.60

High today$21.60

Low today

$21.17

Low today$21.17

Open price

$21.20

Open price$21.20

Volume

1.05M

Volume1.05M

52 Week high

$21.60

52 Week high$21.60

52 Week low

$15.56

52 Week low$15.56

People also own

Based on the portfolios of people who own INVA. This list is generated using Robinhood data, and it’s not a recommendation.